- Formerly Corporate Officer, Takeda Executive Team, leading global portfolio commercialisation and global commercial excellence
- Board Director at F2G (UK/US) and Affibody AB (Sweden)
- Industrial Advisory, private equity group EQT
- Earlier served in various senior operational and strategic roles at Shire, Roche, Abbott (now AbbVie), Schering Plough (now Merck & Co.) and McKinsey & Co. in Europe, US and Asia